Lumentum stock jumps 10% as a new 2x ETF debuts and earnings loom
27 January 2026
1 min read

Lumentum stock jumps 10% as a new 2x ETF debuts and earnings loom

New York, Jan 27, 2026, 15:04 EST — Regular session

Lumentum Holdings Inc (LITE) shares surged 10.4%, hitting $367.04 in Tuesday afternoon trading, after peaking at an intraday high of $373.72. About 2.8 million shares changed hands.

This move is significant as Lumentum has turned into a popular pick for bets on faster connections within cloud data centers, where spending shifts have driven stock swings throughout the supply chain. The company produces optical and photonic components for cloud and communications networks and also sells lasers to industrial sectors. 1

Tradr ETFs unveiled a single-stock leveraged ETF linked to Lumentum, designed to deliver twice the stock’s daily price movement rather than its long-term gains. “We are excited to finally give traders high conviction tools,” said Matt Markiewicz, Tradr’s head of product and capital markets. He stressed these funds are built for short-term trading and reset daily. 2

The bid didn’t just lift Lumentum. Coherent jumped 6.9%, Ciena climbed 5.8%, and Applied Optoelectronics surged 8.2%.

The broader market climbed as well, with the Invesco QQQ Trust gaining roughly 0.9% and the SPDR S&P 500 ETF rising around 0.5%.

Investors are focused on whether the optical rally can hold up when results and guidance hit. For Lumentum, it often boils down to management’s take on cloud and networking demand, plus how solid the quarter appears — shipments, pricing, and the typical timing back-and-forth.

The new ETF could keep trading volume high for now. It offers leverage without the need for margin or options, yet it has the potential to turn an otherwise calm session into a volatile one.

However, after a double-digit surge, the situation is fragile. Should the next update disappoint or if risk appetite fades, those gains in high-beta stocks could evaporate fast.

Lumentum will release its fiscal second-quarter results after the market closes on Feb. 3, followed by a webcast at 5:00 p.m. ET, the company announced. Investors are watching that report and the accompanying outlook commentary as the next key drivers for the stock. 3

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Why SLB stock is climbing today despite a fresh ‘sell’ call
Previous Story

Why SLB stock is climbing today despite a fresh ‘sell’ call

Qualcomm (QCOM) stock price dips as new target cuts flag weaker 2026 handset demand
Next Story

Qualcomm (QCOM) stock price dips as new target cuts flag weaker 2026 handset demand

Go toTop